Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT04254978
PHASE2

Study of Bomedemstat in Participants With Essential Thrombocythemia (IMG-7289-CTP-201/MK-3543-003)

Sponsor: Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA)

View on ClinicalTrials.gov

Summary

This is a Phase 2b open label study of an orally administered LSD1 inhibitor, Bomedemstat (MK-3543, formerly called IMG-7289), in patients with essential thrombocythemia. This study investigates the following: * The safety and tolerability of Bomedemstat * The pharmacodynamic effect of Bomedemstat

Official title: A Phase 2 Multi-Center, Open Label Study to Assess the Safety, Efficacy and Pharmacodynamics of IMG-7289 in Patients With Essential Thrombocythemia

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

73

Start Date

2020-09-08

Completion Date

2023-03-23

Last Updated

2026-05-04

Healthy Volunteers

No

Interventions

DRUG

Bomedemstat

Oral administration

Locations (26)

Local Institution

Jacksonville, Florida, United States

Local Institution

Ann Arbor, Michigan, United States

Local Institution

New York, New York, United States

Local Institution

Durham, North Carolina, United States

Cleveland Clinic

Cleveland, Ohio, United States

Local Institution

Pittsburgh, Pennsylvania, United States

Local Institution

Seattle, Washington, United States

Local Institution

Herston, Brisbane, Australia

Local Institution

Camperdown, New South Wales, Australia

Local Institution

St Leonards, New South Wales, Australia

Local Institution

Southport, Queensland, Australia

Royal Adelaide Hospital

Adelaide, South Australia, Australia

Local Institution

Clayton, Victoria, Australia

Department of Hematology and Stem Cell Transplantation, West German Cancer Center (WTZ)

Essen, Germany

Local Institution

Jena, Germany

Local Institution

Hong Kong, Hong Kong

Local Institution

Alessandria, Italy

Local Institution

Bologna, Italy

CRIMM; Centro Ricerca e Innovazione delle Malattia Mieloproliferative, Azienda ospedaliera Universitaria Careggi

Florence, Italy

Local Institution

Varese, Italy

Local Institution

Auckland, New Zealand

Middlemore Hospital

Auckland, New Zealand

Local Institution

London, United Kingdom

Guys and St Thomas Hospital

London, United Kingdom

Local Institution

London, United Kingdom

Local Institution

Oxford, United Kingdom